Literature DB >> 16341748

The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital.

Ab Fatah Ab Rahman1, Mohamed Izham Mohamed Ibrahim, Hussain Imam Mohamed Ismail, Tan Boon Seng.   

Abstract

OBJECTIVE: (1) To determine the effect of lamotrigine add-on therapy on the seizure frequency and cost in paediatric patients. (2) To determine the prescribing pattern of other antiepileptic drugs (AEDs).
METHOD: A retrospective study of medical records was carried out from October 2000 to June 2001 at the paediatric clinic, Hospital Pulau Pinang. MAIN OUTCOME MEASURE: Seizure frequency, cost of drug and types of AED prescribed.
RESULTS: A total of 209 medical records were retrieved during the study period. Lamotrigine (LTG) was prescribed in 29 patients as add-on therapy. In 18 patients, there was a significant reduction in seizure frequency after the addition of LTG. Approximately 70% experienced a reduction in seizure frequency of more than 50%. Side effects of LTG were considered mild and manageable. However, drug cost after the addition of LTG increased by 103%. In the remaining 180 patients, the most common AED prescribed was sodium valproate (VPA). Only 15% of the patients received combination therapy. Mean monthly cost of monotherapy was found to be RM 24.4 while monthly cost of combination therapy was RM 45.4 (1 Euro-RM 5.00).
CONCLUSION: The majority of paediatric patients in the study are on AED monotherapy and only a small percentage was prescribed lamotrigine. The use of lamotrigine is associated with better seizure control but with an increase in drug cost.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341748     DOI: 10.1007/s11096-005-7912-y

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  11 in total

Review 1.  New antiepileptic drugs: review on drug interactions.

Authors:  Houda Hachad; Isabelle Ragueneau-Majlessi; Rene H Levy
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

Review 2.  Newer therapies in the drug treatment of epilepsy.

Authors:  James W McAuley; Toy S Biederman; Jason C Smith; J Layne Moore
Journal:  Ann Pharmacother       Date:  2002-01       Impact factor: 3.154

3.  Antiepileptic drug utilization in out-patients--a prescribing pattern study.

Authors:  L Peytchev; I Atanasova; D Terziivanov
Journal:  Int J Clin Pharmacol Ther       Date:  1996-10       Impact factor: 1.366

Review 4.  Lamotrigine.

Authors:  F Matsuo
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

5.  Lamotrigine as an add-on therapy in intractable paediatric epilepsy--the Kuala Lumpur Hospital experience.

Authors:  G Vigneswari; A Sofiah; I H Hussain
Journal:  Med J Malaysia       Date:  2001-09

6.  Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.

Authors:  D K Pal; T Das; G Chaudhury; A L Johnson; B G Neville
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

7.  Lamotrigine in treatment of 120 children with epilepsy.

Authors:  E Schlumberger; F Chavez; L Palacios; E Rey; N Pajot; O Dulac
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

8.  Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy.

Authors:  L Cocito; M Maffini; C Loeb
Journal:  Epilepsy Res       Date:  1994-10       Impact factor: 3.045

9.  Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.

Authors:  J Messenheimer; R E Ramsay; L J Willmore; R F Leroy; J J Zielinski; R Mattson; J M Pellock; A M Valakas; G Womble; M Risner
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

10.  Human safety of lamotrigine.

Authors:  T Betts; G Goodwin; R M Withers; A W Yuen
Journal:  Epilepsia       Date:  1991       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.